Brief: GlycoMimetics Says Entered Into Project Agreement With Patheon Manufacturing Services
02/01/2024 21:50
Jan 2 (Reuters) - GlycoMimetics Inc GLYC.O :
* GLYCOMIMETICS INC - ENTERED INTO PROJECT AGREEMENT WITH
PATHEON
MANUFACTURING SERVICES LLC, PART OF THERMO FISHER SCIENTIFIC
* GLYCOMIMETICS - PATHEON WILL MANUFACTURE, SUPPLY CO WITH
DRUG
CANDIDATE, UPROLESELAN,FOR COMMERCIAL SALE SHOULD CO RECEIVE
MARKETING APPROVAL FROM FDA
* GLYCOMIMETICS-IN DEAL, PATHEON WILL MANUFACTURE COMMERCIAL
SUPPLIES OF INJECTABLE UPROLESELAN FROM ACTIVE PHARMACEUTICAL
INGREDIENT SUPPLIED BY CO
* GLYCOMIMETICS INC - UNDER PROJECT AGREEMENT, CO HAS
PROVIDED
PATHEON WITH FORECAST OF REQUIRED ANNUAL VOLUMES THROUGH 2027
Further company coverage: GLYC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescent Biopharma
See all newsBrief: Crescent Biopharma - Potential To Initiate First CR-001 Phase 3 Study In Early 2028
Brief: Crescent Biopharma Announces FDA Clearance Of Ind Application For CR-002, A Pd-L1-Targeted Topoisomerase Inhibitor Adc, For The Treatment Of Solid Tumors
Crescent Biopharma posts smaller-than-expected Q2 net loss
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Crescent Biopharma slips on $125 mln share offering